InsiderTrades

Form 4 for MET MetLife

Accepted 2022-02-24 00:00:00 ET · period of report 2022-02-22 · accession 0001099219-22-000027 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-02-24 2022-02-22 MET TADROS RAMY Pres, U.S. Business F - Tax $68.96 -22.3K 76.4K -23% -$1.54M
DM 2022-02-24 2022-02-22 MET TADROS RAMY Pres, U.S. Business A - Grant — +52.7K 98.8K +115% —
D 2022-02-24 2022-02-22 MET TADROS RAMY Pres, U.S. Business A - Grant $0.00 +25.3K 25.3K New $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-02-22 F D 22,322 $68.96 76,430 D — —
2 Common Common Stock 2022-02-22 A A 8,429 — 54,448 D — — (F1) Restricted stock unit award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
3 Common Common Stock 2022-02-22 A A 44,304 — 98,752 D — — (F2) Shares acquired from the determination of the performance factor for and payout of 2019-2021 performance share award under the MetLife, Inc. 2015 Stock and Incentive Compensation Plan.
4 Derivative Employee Stock Options (right to buy) 2022-02-22 A A 25,283 $0.00 25,283 D $68.96 · — to 2032-02-21 25,283 Common Stock (F4) The options become exercisable in substantially equal installments on each of the first three anniversaries of the grant date.